metastatic/advanced RCC (mRCC) - 1st line (L1) | ||
metastatic/advanced RCC (mRCC) - 1st line (L1) | mRCC - L1 - PDL1 positive | |
avelumab based treatment | ||
avelumab plus axitinib | JAVELIN Renal 101 ... | JAVELIN Renal 101... |
Study type:
delta: difference in rate or median (if available)
- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy -